LOS ANGELES, CA--(Marketwire - Mar 15, 2012) - [ MMRGlobal, Inc. ] (OTCBB: [ MMRF ]) (the "Company"), a leading provider of [ Personal Health Records ] (PHRs), [ MyEsafeDepositBox ] storage solutions, and electronic document management and imaging systems for [ healthcare professionals ], today announced that on March 14, 2012, it filed a Form 8-K with the U.S. Securities and Exchange Commission under Item 8.01 regarding its equity facility with Dutchess Opportunity Fund, II, L.P. The Company stated that it is in the process of seeking to replace its current facility with Dutchess shortly following the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2011. The Company plans on filing on March 30, 2012 with a conference call led by Chairman/CEO Robert H. Lorsch and CFO Ingrid Safranek scheduled for the same day at 1:30 p.m. PDT / 4:30 pm EDT.

According to Lorsch, "The Company is exploring a mix of investor-friendly financing opportunities to fund growth as we get ready to respond to the expanded use of [ Personal Health Records ] mandated under Stage 2 Meaningful Use criteria. It also takes a mix of different types of financing when you are funding retail distribution, which carries significant accounts receivable, making investments in technology and infrastructure to keep pace with mandatory guidelines, and continuing exploitation of our patents and the Company's biotech intellectual property, while maintaining sufficient capital for general operating purposes."

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The [ MyMedicalRecords ] PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, [ MMRPro ], is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId®/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products visit [ www.mmrglobal.com ].

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.